Literature DB >> 19230307

Association between Helicobacter pylori-infection, C-reactive protein and status of B vitamins.

D Stettin1, A Waldmann, A Ströhle, A Hahn.   

Abstract

PURPOSE: Some investigations, but not all, found that a chronic infection with Helicobacter pylori (Hp) is associated with deficiencies in B vitamins, elevated plasma total homocysteine concentrations (tHcy) and increased plasma levels of proinflammatory acute-phase proteins. It has been suggested that these factors promote atherogenesis and therefore could mechanistically explain why people infected with Hp might have an increased risk for cardiovascular diseases (CVD). Therefore we evaluated the association between Hp-infection, concentration of C-reactive protein (CRP), and status of various B vitamins in apparently healthy subjects.
MATERIAL AND METHODS: In 69 subjects with proved Hp-infection and 21 healthy control subjects identified in a cross sectional study, blood samples were collected to determine serum folate, serum vitamin B12, serum methylmalonic acid (MMA), serum CRP and plasma vitamin B6 and plasma total homocysteine (tHcy).
RESULTS: The mean concentration of CRP was significantly higher in the Hp-positive collective than in controls. Although mean concentrations of vitamin B12, B6, and MMA differed between the groups, statistical significance was missed. However, the mean concentrations of homocysteine and folic acid were nearly the same in both groups. In univariate analysis a significant impact of Hp-status was shown on cobalamin (p=0.028; eta square: 0.055), and in multivariate analysis of variance the Hp-status had an impact on vitamin B12-values (p=0.028; eta square 0.057).
CONCLUSIONS: In this study Hp-infection shows no significant impact on status of B vitamins, but has a significant influence on CRP concentration. However, this study does not support the hypothesis that Hp-infection is related to CVD via elevated levels of tHcy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230307     DOI: 10.2478/v10039-008-0050-8

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  6 in total

1.  Antibody levels to persistent pathogens and incident stroke in Mexican Americans.

Authors:  Shawnita Sealy-Jefferson; Brenda W Gillespie; Allison E Aiello; Mary N Haan; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

2.  The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels.

Authors:  Levent Kebapcilar; Oktay Bilgir; Elif Cetinkaya; Murat Akyol; Ferda Bilgir; Giray Bozkaya
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

3.  Helicobacter pylori seropositivity's association with markers of iron, 1-carbon metabolism, and antioxidant status among US adults: a structural equations modeling approach.

Authors:  May A Beydoun; Greg A Dore; Jose A Canas; Hind A Beydoun; Alan B Zonderman
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

4.  Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial.

Authors:  Ali Kachuei; Masoud Amini; Vahid Sebghatollahi; Awat Feizi; Pooria Hamedani; Bijan Iraj
Journal:  J Res Med Sci       Date:  2016-02-23       Impact factor: 1.852

5.  Comparison of gastric juice soluble triggering receptor expressed on myeloid cells and C-reactive protein for detection of Helicobacter pylori infection.

Authors:  Ahmad Piroozmand; Babak Soltani; Mohsen Razavizadeh; Amir Hasan Matini; Gholam Abbas Moosavi; Mohammad Salehi; Siamak Soltani
Journal:  Electron Physician       Date:  2017-12-25

6.  Vitamins and Helicobacter pylori: An Updated Comprehensive Meta-Analysis and Systematic Review.

Authors:  Xianlei Cai; Xueying Li; Yangli Jin; Miaozun Zhang; Yuan Xu; Chao Liang; Yihui Weng; Weiming Yu; Xiuyang Li
Journal:  Front Nutr       Date:  2022-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.